Amarin Corp Plc (AMRN)

[HDGabor]

"FDA has historically considered granting approval for lipid-altering drugs
based on favorable changes in the lipid profile, with the assumption that these changes
would translate into a benefit on clinical outcomes."

Now they need the fact ... no comment.

I still do not understand why: no. What is the worst case for FDA: Vascape does not have any effect of CV (btw: they did not say this), best case: it has ... so why not grant?